CN115105572A - Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing - Google Patents

Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing Download PDF

Info

Publication number
CN115105572A
CN115105572A CN202210587309.XA CN202210587309A CN115105572A CN 115105572 A CN115105572 A CN 115105572A CN 202210587309 A CN202210587309 A CN 202210587309A CN 115105572 A CN115105572 A CN 115105572A
Authority
CN
China
Prior art keywords
parts
oil
cell division
cardiovascular
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210587309.XA
Other languages
Chinese (zh)
Inventor
杨宏涛
张伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Shengbie Biotechnology Development Co ltd
Original Assignee
Shandong Shengbie Biotechnology Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Shengbie Biotechnology Development Co ltd filed Critical Shandong Shengbie Biotechnology Development Co ltd
Priority to CN202210587309.XA priority Critical patent/CN115105572A/en
Publication of CN115105572A publication Critical patent/CN115105572A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/586—Turtles; Tortoises, e.g. terrapins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The invention discloses a tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular, increasing cell division and repairing, which comprises a skin and a content, wherein the content is prepared by the compatibility of the following components: 5-7 parts of linolenic acid type edible vegetable oil, 4-6 parts of turtle oil, 6-8 parts of fish oil, 3-5 parts of Chinese softshell turtle powder, 4-6 parts of resistant dextrin, 6-9 parts of sucrose, 8-12 parts of vitamin C, 0.4-0.6 part of citric acid, 0.3-0.5 part of microcrystalline cellulose, 0.1-0.3 part of a compound thickener, 4-6 parts of sea buckthorn oil, 2-4 parts of wolfberry fruit oil, 2-4 parts of silybum marianum seed oil, 10-14 parts of natto, 10-16 parts of red yeast rice, 12-16 parts of sea buckthorn powder, 12-16 parts of rhizoma polygonati and 12-16 parts of cordyceps militaris; the formula can inhibit tumor, regulate hyperlipidemia, blood viscosity, atherosclerosis, hemidysesthesia, and night paroxysmal dyspnea, and increase cell division to repair human tissue.

Description

Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing
Technical Field
The invention relates to a medicament for treating cardiovascular and cerebrovascular diseases, in particular to a tissue formula capable of inhibiting tumor, conditioning cardiovascular and cerebrovascular diseases, increasing cell division and repairing.
Background
With the change of life style and social environment, cardiovascular and cerebrovascular risk factors are continuously increased, the morbidity and mortality of cardiovascular and cerebrovascular diseases such as hypertension, coronary heart disease and atherosclerosis of common people in China are in an increasing stage, and the onset age structure is gradually younger. The data show that the mortality rate of cardiovascular and cerebrovascular diseases is the top in China and higher than that of tumors and other diseases, and the mortality rate of cardiovascular and cerebrovascular diseases of urban and rural residents in China is kept on the continuously rising trend. The total hospitalization cost of cardiovascular and cerebrovascular diseases is rapidly increased, and the annual speed increase is much higher than the national production total value increase in 2004 to the present. The burden of cardiovascular and cerebrovascular diseases in China is gradually increased, which becomes a great public health problem and the prevention and treatment of the cardiovascular and cerebrovascular diseases are not easy.
At present, the method of combining traditional Chinese medicine with Chinese and western medicine is a trend of preventing and treating cardiovascular and cerebrovascular diseases in recent years, and the traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases in China mainly takes syndrome differentiation and overall treatment as principles in long-term practice, so that a series of effective formulas and Chinese patent medicines are formed. In clinical treatment, the Chinese patent medicine for treating cardiovascular and cerebrovascular diseases has the following advantages: can be used in various links of disease treatment starting from integral adjustment. The traditional Chinese medicine composition has the effects of treating the symptoms of the disease in an urgent condition and treating the root cause of the disease in a slow condition, has the advantages of fixed dosage form, clear drug effect, stable curative effect, more target spots, less side effect and the like, is suitable for long-term rehabilitation after operation in the aspect of use, has relatively low cost, and can reduce the economic burden of patients to a great extent. The development of formulations in this respect is advantageous for meeting clinical therapeutic needs. From the pathological point of view, after the cardiovascular and cerebrovascular diseases are recovered, a plurality of micro tissues in a human body are damaged, and the damaged tissues need to be gradually repaired by the human body through cell division, but the existing medicines for treating the cardiovascular and cerebrovascular diseases can only improve and treat corresponding diseases and have no effect of repairing the tissues of the human body.
Disclosure of Invention
The invention aims at the problems and provides a tissue repair formula capable of inhibiting tumor, conditioning heart and cerebral vessels, increasing cell division, which not only treats the diseases of hyperlipidemia, blood viscosity, atherosclerosis, partial somatosensory disorder and paroxysmal dyspnea at night, but also can increase cell division to achieve the purpose of repairing human tissues.
In order to achieve the technical purpose, the invention adopts a formula capable of inhibiting tumor conditioning cardiovascular and cerebrovascular, increasing cell division and repairing tissues, which comprises a skin and a content, wherein the content is prepared by the compatibility of medicines of the following components: 5-7 parts of linolenic acid type edible vegetable oil, 4-6 parts of turtle oil, 6-8 parts of fish oil, 3-5 parts of Chinese softshell turtle powder, 4-6 parts of resistant dextrin, 6-9 parts of sucrose, 8-12 parts of vitamin C, 0.4-0.6 part of citric acid, 0.3-0.5 part of microcrystalline cellulose, 0.1-0.3 part of a compound thickener, 4-6 parts of sea buckthorn oil, 2-4 parts of wolfberry fruit oil, 2-4 parts of silybum marianum seed oil, 10-14 parts of natto, 10-16 parts of red yeast rice, 12-16 parts of sea buckthorn powder, 12-16 parts of rhizoma polygonati and 12-16 parts of cordyceps militaris;
the outer skin is prepared from the following materials in a compatibility manner: 10-20 parts of gelatin, 10-20 parts of sorbitol solution, 10-16 parts of glycerol and 40-60 parts of water.
Preferably, the weight parts are weight measurement units of gram, two, jin or kg.
Preferably, the formula is pills or granules.
The invention further discloses a formula for conditioning cardiovascular and cerebrovascular diseases, increasing cell division and repairing human tissues, which comprises the following steps:
(1) mixing semen Sojae Preparatum, Red Rice, rhizoma Polygonati, and Cordyceps militaris, sterilizing, oven drying, and grinding into powder;
(2) mixing the milled powder in the step (1) with linolenic acid type edible vegetable oil, turtle oil, fish oil, Chinese soft-shelled turtle powder, resistant dextrin, sucrose, vitamins, citric acid, microcrystalline cellulose, a compound thickener, sea buckthorn oil, medlar seed oil, silybum marianum seed oil and sea buckthorn powder which are well mixed in parts by weight, and then putting the mixture into a stirrer to be fully stirred;
(3) preparing the mixture obtained in the step (2) into pills or granules by using a pharmaceutical machine;
(4) mixing gelatin, sorbitol solution, glycerol and water in parts by weight, and mixing to obtain paste; mixing the pills or granules obtained in the step (3) into the paste according to the parts by weight, and then fully stirring and mixing;
(5) and (5) preparing the mixture obtained in the step (4) into tablets, pills or granules by using a pharmaceutical machine, and then packaging.
Preferably, the formulation is used as follows: when the formulation is a tablet or granule, the drug is orally taken 2-3 times a day, 3 tablets or 10g of the drug are orally taken each time.
Optionally, the formula of the invention is used for inhibiting tumors, treating coronary heart disease, hyperlipidemia, blood viscosity, atherosclerosis, hemiparesthesia, nocturnal paroxysmal dyspnea, palpitation and perimenopausal syndrome, and can increase cell division and repair human tissues.
In the formula of the invention, the cordyceps militaris is edible and medicinal fungi, the protein content of the cordyceps militaris is up to 40.7 percent, and the contained amino acids necessary for human bodies are complete in variety, sufficient in quantity and proper in proportion. The artificially cultivated cordyceps militaris also contains abundant vitamins, minerals and the like, and has good edible value. The cordyceps militaris stroma can be used as a medicine, has mild nature and sweet taste, benefits lung and kidney, stops bleeding and reduces phlegm, and can be generally used for treating pulmonary tuberculosis, weakness of old people, anemia and weakness and the like. Cordyceps militaris contains abundant cordycepic acid, cordycepin, ergosterol, etc., and has effects of expanding trachea, tranquilizing, resisting various bacteria, and lowering blood pressure.
In the formula of the invention, the food of the sealwort is sweet and tasty, is a main material of a plurality of traditional Chinese medicine formulas, and has a long-standing tradition in Qinling forest regions. Rhizoma Polygonati can be used for treating weakness of spleen and stomach, asthenia, xerostomia, cough due to lung deficiency, essence and blood deficiency, internal heat, diabetes, pulmonary tuberculosis, and tinea.
In the formula of the invention, the red yeast rice has the effects of purifying blood and clearing toxins in the blood, and because the active ingredients contained in the red yeast rice can inhibit the absorption of human bodies to cholesterol and clear the fat accumulated in the blood, the red yeast rice can reduce the viscosity of the blood, promote the blood circulation, prevent the blood pressure and the blood fat from rising and prevent the cardiovascular and cerebrovascular diseases caused by the invasion of the human bodies.
The natto in the formula is a micro-ecological food which is formed by fermenting small-particle soybeans through bacillus natto and is a food and health-care product which is favored by Japan and southeast Asia. The natto contains natto peptide, nattokinase, superoxide dismutase, polysaccharide, isoflavone, saponin, lecithin, vitamin E, vitamin K, etc., and has effects of inhibiting intestinal harmful bacteria, regulating intestinal flora balance, and improving digestion function. Natto contains about 60% of water, 20% of crude protein, 8% of crude fat, 2% of crude fiber and 2% of ash.
The seabuckthorn oil in the formula has the effects and effects of regulating gastrointestinal functions, protecting the liver and blood vessels, preventing tumors, relieving cough and asthma and the like, contains unsaturated fatty acids, flavones, vitamins, trace elements and the like, and also contains a plurality of bioactive substances. Firstly, the seabuckthorn oil can effectively regulate the functions of the gastrointestinal tract and relieve gastrectasia, abdominal distension, constipation and the like. The effect and function of the seabuckthorn oil can protect the liver, prevent cirrhosis caused by hepatitis and fatty liver, and improve the indexes of the liver function to a certain extent. Thirdly, the effect and the function of the seabuckthorn oil can reduce blood pressure, reduce blood fat and protect blood vessels, so the seabuckthorn oil also has certain health care function on cardiovascular and cerebrovascular diseases. The fourth seabuckthorn oil can also improve the immunity of the organism, so the seabuckthorn oil also has a certain effect on preventing tumors. Fifthly, the seabuckthorn oil can relieve cough and asthma, benefit lung and reduce phlegm, and can play an auxiliary treatment role aiming at long-term cough and phlegm and the symptom of dyspnea.
The content of unsaturated fatty acid, linolenic acid and oleic acid in the medlar seed oil in the formula of the invention is as high as more than 85%. And contains a large amount of phospholipid, and can reduce plasma cholesterol, reduce cholesterol deposition on blood vessel walls, and prevent blood fat and atherosclerosis.
The silybum marianum oil in the formula can effectively prevent liver injury, can form a layer of protective film on liver cells, relieves the damage to the liver caused by excessive alcohol, can assist the treatment of liver diseases, has the functions of strengthening and repairing the liver, can promote the repair of the liver cells through the synthesis of protein, has a very good function of promoting the new growth of the cells, has a certain treatment effect on the liver function of a hepatitis patient, can reduce the damage of the liver cells damaged by free radicals, and also has a certain radiation resistance function.
Detailed Description
The present invention will be further described with reference to the following embodiments.
Example 1
A tissue formula for inhibiting tumor, regulating cardiovascular and cerebrovascular, increasing cell division and repairing tissue comprises cortex and content.
In this embodiment, the content is prepared by the following ingredients: 5 parts of linolenic acid type edible vegetable oil, 4 parts of turtle oil, 6 parts of fish oil, 3 parts of Chinese softshell turtle powder, 4 parts of resistant dextrin, 6 parts of sucrose, 8 parts of vitamin C, 0.4 part of citric acid, 0.3 part of microcrystalline cellulose, 0.1 part of compound thickening agent, 4 parts of sea buckthorn oil, 2 parts of medlar seed oil, 2 parts of silybum marianum seed oil, 10 parts of natto, 10 parts of red yeast rice, 12 parts of sea buckthorn powder, 12 parts of rhizoma polygonati and 12 parts of cordyceps militaris;
in this embodiment, the sheath is formed by compounding the following materials: 10 parts of gelatin, 10 parts of sorbitol solution, 10 parts of glycerol and 40 parts of water.
In the embodiment, the formula is in grams, and the formula is pills or granules.
The embodiment next discloses a formula for repairing human tissues by increasing cell division and conditioning cardiovascular and cerebrovascular diseases, and the preparation method of the formula comprises the following steps:
(1) mixing semen Sojae Preparatum, Red Rice, rhizoma Polygonati, and Cordyceps militaris, sterilizing, oven drying, and grinding into powder;
(2) mixing the milled powder in the step (1) with linolenic acid type edible vegetable oil, turtle oil, fish oil, Chinese soft-shelled turtle powder, resistant dextrin, sucrose, vitamins, citric acid, microcrystalline cellulose, a compound thickener, sea buckthorn oil, medlar seed oil, silybum marianum seed oil and sea buckthorn powder which are well mixed in parts by weight, and then putting the mixture into a stirrer to be fully stirred;
(3) preparing the mixture obtained in the step (2) into pills or granules by using a pharmaceutical machine;
(4) mixing gelatin, sorbitol solution, glycerol and water in parts by weight, and mixing to obtain paste; mixing the pills or granules obtained in the step (3) into the paste according to the weight part, and then fully stirring and mixing;
(5) and (5) preparing the mixture obtained in the step (4) into tablets, pills or granules by using a pharmaceutical machine, and then packaging.
The application method of the formulation of this example is as follows: when the formulation is tablet or granule, the medicine is orally taken 2-3 times a day, 3 tablets or 10g of the medicine is orally taken each time.
The formula of the embodiment is used for inhibiting tumors, treating coronary heart disease, hyperlipidemia, blood viscosity, atherosclerosis, hemiesthesia, paroxysmal dyspnea at night, palpitation and perimenopausal syndrome, and can increase cell division and repair human tissues.
Example 2
A tissue formula for inhibiting tumor, regulating cardiovascular and cerebrovascular, increasing cell division and repairing tissue comprises cortex and content.
In this embodiment, the content is prepared by the following ingredients: 7 parts of linolenic acid type edible vegetable oil, 6 parts of turtle oil, 8 parts of fish oil, 5 parts of Chinese softshell turtle powder, 6 parts of resistant dextrin, 9 parts of sucrose, 12 parts of vitamin C, 0.6 part of citric acid, 0.5 part of microcrystalline cellulose, 0.3 part of a compound thickener, 6 parts of sea buckthorn oil, 4 parts of wolfberry fruit oil, 4 parts of silybum marianum seed oil, 14 parts of natto, 16 parts of red yeast rice, 16 parts of sea buckthorn powder, 16 parts of rhizoma polygonati and 16 parts of cordyceps militaris;
in this embodiment, the sheath is made of the following materials: 20 parts of gelatin, 20 parts of sorbitol solution, 16 parts of glycerol and 60 parts of water.
The weight parts of the formula in the embodiment are jin, and the formula is pills and granules.
The embodiment next discloses a formula for repairing human tissues by increasing cell division and conditioning cardiovascular and cerebrovascular diseases, and the preparation method of the formula comprises the following steps:
(1) mixing semen Sojae Preparatum, Red Rice, rhizoma Polygonati, and Cordyceps militaris, sterilizing, oven drying, and grinding into powder;
(2) mixing the milled powder in the step (1) with linolenic acid type edible vegetable oil, turtle oil, fish oil, Chinese soft-shelled turtle powder, resistant dextrin, sucrose, vitamins, citric acid, microcrystalline cellulose, a compound thickener, sea buckthorn oil, medlar seed oil, silybum marianum seed oil and sea buckthorn powder which are well mixed in parts by weight, and then putting the mixture into a stirrer to be fully stirred;
(3) preparing the mixture obtained in the step (2) into pills or granules by using a pharmaceutical machine;
(4) mixing gelatin, sorbitol solution, glycerol and water in parts by weight, and mixing to obtain paste; mixing the pills or granules obtained in the step (3) into the paste according to the parts by weight, and then fully stirring and mixing;
(5) and (5) preparing the mixture obtained in the step (4) into tablets, pills or granules by using a pharmaceutical machine, and then packaging.
The application method of the formulation of this example is as follows: when the formulation is tablet or granule, the medicine is orally taken for 2-3 times a day, and the medicine is orally taken for 3 tablets or 10g each time.
The formula of the embodiment is used for inhibiting tumors, treating coronary heart disease, hyperlipidemia, blood viscosity, atherosclerosis, hemisensory disturbance, nocturnal paroxysmal dyspnea, palpitation and perimenopausal syndrome, and can increase cell division and repair human tissues.
Example 3
A tissue formula for inhibiting tumor, regulating cardiovascular and cerebrovascular, increasing cell division and repairing tissue comprises cortex and content.
In this embodiment, the content is prepared by the following ingredients: 6 parts of linolenic acid type edible vegetable oil, 5 parts of turtle oil, 7 parts of fish oil, 4 parts of Chinese softshell turtle powder, 5 parts of resistant dextrin, 7 parts of sucrose, 10 parts of vitamin C, 0.5 part of citric acid, 0.4 part of microcrystalline cellulose, 0.2 part of a compound thickener, 5 parts of sea buckthorn oil, 3 parts of wolfberry fruit oil, 3 parts of silybum marianum seed oil, 12 parts of natto, 13 parts of red yeast rice, 14 parts of sea buckthorn powder, 14 parts of rhizoma polygonati and 14 parts of cordyceps militaris;
in this embodiment, the sheath is formed by compounding the following materials: 15 parts of gelatin, 15 parts of sorbitol solution, 13 parts of glycerol and 50 parts of water.
In the embodiment, the formula is kilogram, and the formula is pills or granules.
The embodiment next discloses a formula for repairing human tissues by increasing cell division and conditioning cardiovascular and cerebrovascular diseases, and the preparation method of the formula comprises the following steps:
(1) mixing semen Sojae Preparatum, Red Rice, rhizoma Polygonati, and Cordyceps militaris, sterilizing, oven drying, and grinding into powder;
(2) mixing the milled powder in the step (1) with linolenic acid type edible vegetable oil, turtle oil, fish oil, Chinese soft-shelled turtle powder, resistant dextrin, sucrose, vitamins, citric acid, microcrystalline cellulose, a compound thickener, sea buckthorn oil, medlar seed oil, silybum marianum seed oil and sea buckthorn powder which are well mixed in parts by weight, and then putting the mixture into a stirrer to be fully stirred;
(3) preparing the mixture obtained in the step (2) into pills or granules by using a pharmaceutical machine;
(4) mixing gelatin, sorbitol solution, glycerol and water in parts by weight, and mixing to obtain paste; mixing the pills or granules obtained in the step (3) into the paste according to the parts by weight, and then fully stirring and mixing;
(5) and (5) preparing the mixture obtained in the step (4) into tablets, pills or granules by using a pharmaceutical machine, and then packaging.
The formula of the embodiment is used for inhibiting tumors, treating coronary heart disease, hyperlipidemia, blood viscosity, atherosclerosis, hemiesthesia, paroxysmal dyspnea at night, palpitation and perimenopausal syndrome, and can increase cell division and repair human tissues.
The therapeutic effect judgment standard of the formula of the invention is as follows:
the method has the following advantages: the corresponding discomfort symptoms of the patient are eliminated or reduced. Such as: the patients have no dizziness, headache, head distension, chest distress and chest pain feeling, or the degree is obviously improved; the related indexes of blood pressure, blood viscosity, blood fat and the like are normal, the daily life of the food is normal, and the self-care ability of life is obviously enhanced.
And (4) invalidation: compared with the medicine before treatment, the medicine has no improvement on all aspects of patients.
The clinical case observation of patients who adopt the pharmaceutical composition to treat diseases or symptoms such as coronary heart disease, arteriosclerosis, palpitation, perimenopausal syndrome and the like is carried out to further explain the curative effect of the pharmaceutical composition of the invention:
case one: in yet another case, men were diagnosed at 49 years old, 3 months in 2021. The chest distress and chest pain intercropping is 1 year, the activity endurance is reduced, hyperlipidemia and blood viscosity are caused, atherosclerosis is caused, the hypertension is not high, the mild fatty liver and the blood fat are high in hospital hospitalization, rosuvastatin and aspirin are taken for 3 months, the symptoms are not improved for diagnosis, the medicine is required to be taken, after the medicine is taken for 1 month according to the requirement, the upper symptoms are obviously reduced, and the chest distress and chest pain does not occur in nearly 1 year.
In case two, there is some allergy in Shen, women, 66 years old, Jiangxi Nanchang who often have dizziness and chest stuffiness, and chest stuffiness and pain can be induced by activities. Hypertension was found in 2019, and the diagnosis in 20120 was "coronary heart disease, proximal stenosis of right coronary 70%, anterior descending and circumflex stenosis 30% -50%". Usually, dizziness and heaviness of the head often occur, chest distress and shortness of breath exist, movement or excitement often occur, chest distress and pain frequently occur, the mouth is bitter and dry, the mouth is sticky and greasy, the appetite is not fragrant, abdominal distension exists sometimes, the formula is orally taken for 5 months according to the requirement, the symptoms are obviously relieved, and the state of an illness is stable. In 2021, coronary angiography at 9 months reduced 70% of the original right coronary proximal stenosis to about 50%, and 30% of the anterior descending and circumflex branch stenosis.
The above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the protection scope of the present invention.

Claims (6)

1. The tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing comprises a skin and contents, and is characterized in that the contents are prepared from the following medicines in a compatibility mode: 5-7 parts of linolenic acid type edible vegetable oil, 4-6 parts of turtle oil, 6-8 parts of fish oil, 3-5 parts of Chinese softshell turtle powder, 4-6 parts of resistant dextrin, 6-9 parts of sucrose, 8-12 parts of vitamin C, 0.4-0.6 part of citric acid, 0.3-0.5 part of microcrystalline cellulose, 0.1-0.3 part of a compound thickener, 4-6 parts of sea buckthorn oil, 2-4 parts of wolfberry fruit oil, 2-4 parts of silybum marianum seed oil, 10-14 parts of natto, 10-16 parts of red yeast rice, 12-16 parts of sea buckthorn powder, 12-16 parts of rhizoma polygonati and 12-16 parts of cordyceps militaris;
the outer skin is prepared from the following materials in a compatibility manner: 10-20 parts of gelatin, 10-20 parts of sorbitol solution, 10-16 parts of glycerol and 40-60 parts of water.
2. The tissue formulation for repairing by inhibiting tumor conditioning cardiovascular and cerebrovascular cell division according to claim 1, wherein the weight portion is the unit of weight of gram, two, jin or kg.
3. The tissue formulation for repairing tissue by inhibiting tumor conditioning, cardiovascular and cerebrovascular cell division according to claim 1, wherein the formulation is pill or granule.
4. The tissue formulation for repairing tissue by inhibiting tumor conditioning, cardiovascular and cerebrovascular cell division increase according to claim 1, wherein the formulation is prepared by the method comprising:
mixing semen Sojae Preparatum, Red Rice, rhizoma Polygonati, and Cordyceps militaris, sterilizing, oven drying, and grinding into powder;
mixing the milled powder in the step (1) with linolenic acid type edible vegetable oil, turtle oil, fish oil, Chinese soft-shelled turtle powder, resistant dextrin, sucrose, vitamins, citric acid, microcrystalline cellulose, a compound thickener, sea buckthorn oil, medlar seed oil, silybum marianum seed oil and sea buckthorn powder which are well mixed in parts by weight, and then putting the mixture into a stirrer to be fully stirred;
preparing the mixture obtained in the step (2) into pills or granules by using a pharmaceutical machine;
mixing gelatin, sorbitol solution, glycerol and water in parts by weight, and mixing to obtain paste; mixing the pills or granules obtained in the step (3) into the paste according to the weight part, and then fully stirring and mixing;
and (5) preparing the mixture obtained in the step (4) into tablets, pills or granules by using a pharmaceutical machine, and then packaging.
5. The tissue repair formulation for inhibiting tumor conditioning, cardiovascular and cerebrovascular cell division increase according to claim 1, wherein the formulation is used in the following manner: when the formulation is a tablet or granule, the drug is orally taken 2-3 times a day, 3 tablets or 10g of the drug are orally taken each time.
6. The tissue repair formulation according to claim 1, for inhibiting tumor, treating coronary heart disease, hyperlipidemia, blood viscosity, atherosclerosis, hemiparesis, nocturnal paroxysmal dyspnea, palpitation, perimenopausal syndrome, and increasing cell division repair in human tissue.
CN202210587309.XA 2022-05-27 2022-05-27 Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing Pending CN115105572A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210587309.XA CN115105572A (en) 2022-05-27 2022-05-27 Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210587309.XA CN115105572A (en) 2022-05-27 2022-05-27 Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing

Publications (1)

Publication Number Publication Date
CN115105572A true CN115105572A (en) 2022-09-27

Family

ID=83326825

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210587309.XA Pending CN115105572A (en) 2022-05-27 2022-05-27 Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing

Country Status (1)

Country Link
CN (1) CN115105572A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113080447A (en) * 2021-04-09 2021-07-09 文山厚德堂三七开发有限责任公司 Food therapy product suitable for hyperlipidemia rehabilitation, stasis elimination and blood stasis removal and qi and blood regulation
CN113812624A (en) * 2021-11-09 2021-12-21 威海康贝尔生物技术有限公司 Food therapy formula beneficial to heart and cerebral vessels and capable of regulating qi and blood and preparation method of food therapy formula

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113080447A (en) * 2021-04-09 2021-07-09 文山厚德堂三七开发有限责任公司 Food therapy product suitable for hyperlipidemia rehabilitation, stasis elimination and blood stasis removal and qi and blood regulation
CN113812624A (en) * 2021-11-09 2021-12-21 威海康贝尔生物技术有限公司 Food therapy formula beneficial to heart and cerebral vessels and capable of regulating qi and blood and preparation method of food therapy formula

Similar Documents

Publication Publication Date Title
CN101695376B (en) Health-care food for preventing diabetes
CN109674958B (en) Traditional Chinese medicine composition with effect of reducing uric acid and preparation method and application thereof
CN106666312A (en) Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof
US20200147166A1 (en) Health supplement food for promotion of hair growth, mitigation and alleviation of hair loss, regulation of blood glucose, and alleviation and relief of gastric disorder symptoms
CN111588042A (en) Dietary nutrition conditioning food for assisting in reducing uric acid and controlling gout
CN109400750B (en) Pharmaceutical composition with uric acid reducing effect
CN101507800A (en) Ludisia discolor and pumpkin composite health care product capable of reducing blood sugar and preparation method thereof
KR20130063074A (en) Blood glucose and blood pressure decrease action composition
CN107136281A (en) It is a kind of to be used to improve kelp cordyceps sinensis pressed candy of women renal function and preparation method thereof
JPWO2005094858A1 (en) Antidiabetic composition
CN1127349C (en) Antilipemic slimming tea prepn
CN115105572A (en) Tissue formula capable of inhibiting tumor conditioning, cardiovascular and cerebrovascular diseases, increasing cell division and repairing
CN104207121B (en) A kind of immunity that improves reduces by three high food therapeutic healths
KR100514132B1 (en) Composition and kit for losing body weight
CN103933282B (en) A kind of Chinese medicinal capsule for treating diabetes
CN110693029A (en) Mulberry leaf and bitter gourd functional food capable of reducing blood sugar
CN105733880A (en) Composite hazelnut wine brewed from hazelnut meal
CN102626471B (en) Traditional Chinese medicine composition with effects of anti-anaphylaxis, desensitization, repair and regeneration
CN110959721A (en) Solid beverage of edible herbal tea
CN105031248A (en) Health care product which contains Se-enriched cordyceps and is capable of assisting in blood sugar level regulation
CN104173745A (en) Nourishing and body-building Mongolian medicine
CN112076305A (en) A Chinese medicinal oral and topical stock solution mixture for treating metabolic syndrome and resisting bacteria and inflammation
CN115089676B (en) Application of swertia mileensis-containing traditional Chinese medicine compound composition in preparation of secondary prevention medicine for treating coronary heart disease
CN109289017A (en) For clearing up the composition and preparation method of blood vessel and blood
CN114767794B (en) Traditional Chinese medicine for treating arterial plaque

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination